Insight Molecular Diagnostics Inc. Common Stock

IMDXNASDAQ • USD
ThemeGenomics & Precision Med.›Genetic Testing & Diagnostics
6.21 USD
↘ 0.32 (4.90%)AT CLOSE (11:59 AM EDT)
6.26
↗ 0.05 (0.81%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
6.26
↗ 0.05 (0.81%)
🔴Market: CLOSED
Open?$6.53
High?$6.53
Low?$6.04
Prev. Close?$6.53
Volume?238.2K
Avg. Volume?434.0K
VWAP?$6.32
Rel. Volume?0.55x
Bid / Ask
Bid?$6.10 × 500
Ask?$6.80 × 100
Spread?$0.70
Midpoint?$6.45
Valuation & Ratios
Market Cap?200.5M
Shares Out?32.3M
Float?19.2M
Float %?67.1%
P/E Ratio?N/A
P/B Ratio?-18.76
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A

Insight Molecular Diagnostics Inc. Common Stock (IMDX) is currently trading at $6.21. IMDX shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (447.5%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of May 29, 2026.

News
Profile
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Themes
Healthcare - Genomics & Precision Medicine›Genetic Testing & Diagnostics
Employees
58
Market Cap
210.9M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
www.imdxinc.com
Listed
2015-12-30
Address
2 INTERNATIONAL PLAZA DR., SUITE 510
NASHVILLE, TN 37217
Phone: 949-409-7600
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
65
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.56Distress
Confidence?29%Very Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.15%Elevated
Short Interest?1.2M
Days to Cover?2.1
Free Float19.2M
Avg Daily Volume561.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.48Strong
Quick Ratio?2.45Strong
Cash Ratio?2.35Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-18.76CHEAP▾
P/S?
Peers
100
S&P
3
102.88HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
88.42HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
447.5%STRONG▾
ROA?
S&P
3
-118.3%WEAK▾
Cash Flow & Enterprise
FCF?$-27456000
Enterprise Value?$172.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist